Ampio Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.12.20	Ampio Pharma Gets Feedback From FDA On Its Treatment For Osteoarthritis (RTTNews)
28.10.20	Ampio Begins Phase 1 Trial Of Inhaled Ampion For COVID-19 Patients With Respiratory Distress (RTTNews)
10.09.20	AMPE Says Ampion Improves COVID-19 Symptoms, AMYT At Ease, ITCI Impresses With Depression Trial Data (RTTNews)
09.09.20	Ampio Reports Positive Results For Ampion Treatment In COVID-19 Patients; Shares Up 8% (RTTNews)
19.08.20	Ampio Pharmaceuticals Updates On COVID-19 Clinical Trial Activities - Quick Facts (RTTNews)
22.05.20	Ampio Pharma Develops Therapies For Patients Infected With COVID-19; Stock Up (RTTNews)
25.03.20	AMPE Suspends Recruitment In Study On Virus Risks, IMAC Rockets, SCPH On Watch (RTTNews)
09.08.18	AMPE Craters On Ampion Update, CTXR Keeps Hitting New Lows, DEPO To File NDA (RTTNews)
07.08.18	Recheck Propels PTGX, Analysts Boost Price Target On ICPT, Watch Out For AMPE (RTTNews)
05.06.18	Ampio Provides Scientific Update and Links to Peer Review Publications (PR Newswire)
29.05.18	Ampio Updates Regulatory and IP Activities (PR Newswire)
29.05.18	Moleaer™ Secures Over $6 Million Investment led by Energy Innovation Capital (PR Newswire)
22.05.18	Ampio Updates Scientific presentations and publications on Ampion™ (PR Newswire)
14.05.18	Ampio Provides Corporate Update (PR Newswire)
02.05.18	The Pivotal Trial Results on Ampion™ (AP-003-C) Was Accepted for Publication in a Peer-Reviewed Medical Journal (PR Newswire)
12.04.18	Ampio Updates Regulatory, Clinical and NYSE Activities (PR Newswire)
03.04.18	Ampio Updates Regulatory and Clinical Activities (PR Newswire)
26.03.18	Evidence for Delay of Total Knee Replacement (TKR) for Patients with Severe Osteoarthritis of the Knee Receiving Three Intra-articular (IA) Ampion™ Injections (PR Newswire)
20.03.18	Chipotle Names Chris Brandt Chief Marketing Officer (PR Newswire)
16.03.18	Eagle's Flight Publishes Guide to Improving Patient Outcomes (PR Newswire)
15.03.18	Ampio Pharmaceuticals Provides Corporate Update Following Conference Call (PR Newswire)
06.03.18	Ampio Hosting Conference Call, Wednesday, March 7, 5:00 pm EST (PR Newswire)
17.01.18	Outpost Medicine Announces Acceptance of Two Investigational New Drug Applications for OP-687 by U.S. FDA (PR Newswire)
09.01.18	Deluxe Unifies Distribution Business with Strategic New Appointments (PR Newswire)
09.01.18	Fortem Technologies, Inc. Announces TrueView R20: The Most Compact, Long Range, Detect-And-Avoid Solution For Safe Drone Operations (PR Newswire)
14.12.17	Ampio Pharmaceuticals Reports Positive Results for both Primary and Secondary Endpoints of Pivotal Phase 3 Trial of Ampion™ in Severe Osteoarthritis-of-the Knee (OAK) (PR Newswire)
30.11.17	Ampio Pharmaceuticals Announces Engagement of LaVoieHealthScience for Integrated Public and Investor Relations (PR Newswire)
22.11.17	Ampio Announces Publication of Ampion™ Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal (PR Newswire)
17.11.17	Ampio Pharmaceuticals, Inc. Announces Continued Listing Plan Accepted by NYSE American (PR Newswire)
15.11.17	Ampio Announces Start of Open Label Extension Study to Support Commercial Label of Repeat Administration of Ampion™ in Severe Osteoarthritis of the Knee (PR Newswire)
12.10.17	Ampio Announces Accepted Publication of Pooled Ampion™ Clinical Trial Results in Patients with Severe Osteoarthritis of the Knee (PR Newswire)
19.09.17	Stock Performance Review on Biotech Industry -- Intrexon, Ampio Pharma, AmpliPhi Biosciences, and CorMedix (PR Newswire)
18.09.17	Ampio Completes Enrollment of Patients in 12-Week Pivotal Trial (PR Newswire)
08.09.17	Christmas Comes Early For KURA, ANTH On Track, ABBV Hits All-time High (RTTNews)
07.09.17	Ampio Discloses Receipt of Notice from NYSE American and Has Until March 1, 2019, to Gain Compliance (PR Newswire)
09.08.17	Daily Technical Summary Reports on Biotech Stocks -- Axovant Sciences, Ampio Pharma, ImmunoCellular Therapeutics, and Synthetic Biologics (PR Newswire)
08.08.17	Ampio Announces the Allowance of a Composition and Methods Patent in the USA Using Ampion™ in Conjunction with Stem Cells (PR Newswire)
06.07.17	Ampio Hosting Conference Call, Wednesday, July 12, 4:30 pm EDT (PR Newswire)
22.06.17	Ampio Injects First Patient in Final Pivotal Clinical Trial for Ampion™ BLA (PR Newswire)
12.06.17	Ampio Announces Appointment of Interim Chief Financial Officer (PR Newswire)
08.06.17	Ampio Pharmaceuticals, Inc. Announces Closing of Registered Direct Offering (PR Newswire)
05.05.17	Ampion™ Human Macrophage Study Results Accepted for Presentation at the 2017 Annual AAST Meeting in Baltimore (PR Newswire)
01.05.17	Ampio Initiates Pivotal Trial of Ampion™ (PR Newswire)
28.03.17	Ampio Pharmaceuticals Amends Warrant Agreement (PR Newswire)
23.03.17	Ampio Updates Intellectual Property and Regulatory Exclusivity Strategy to Support the Commercialization of Ampion™ (PR Newswire)
01.03.17	Ampio Hosting Conference Call Tuesday, March 7, 4:30pm EST (PR Newswire)
27.02.17	Ampio Receives Guidance from the FDA and Proposes a Path for Approval for Single-Injection Ampion™ for the Treatment of Pain Due to Severe Osteoarthritis of the Knee (PR Newswire)
01.07.16	It's A Ten For Humira, AMPE Drubbed By PIVOT Data, CYNA Awaits Data In Q3 (RTTNews)
21.04.15	AMPE Severely Hurt, INGN Put On Notice, NYMX On The Rise, SGEN Gets FDA Date (RTTNews)
13.11.14	AMPE Takes Ampion In Stride, GLMD For The Long Haul, MSLP On Watch (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	603.80	1.04 %	K V
CieFinRichemont	176.20	0.26 %	K V
Givaudan	3’928.00	0.08 %	K V
Novartis	96.11	0.02 %	K V
Part Grp Hldg	1’378.50	-0.04 %	K V
Nestle	77.50	-0.46 %	K V
Swisscom	507.50	-0.49 %	K V
Kuehne+Nagel Int	200.60	-1.28 %	K V
Sonova Hldg	309.70	-1.99 %	K V
UBS Group	30.00	-5.63 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Ampio Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten